Related references
Note: Only part of the references are listed.TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization
Kristin L. Moffitt et al.
CELL HOST & MICROBE (2011)
A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children
Carlos G. Grijalva et al.
CURRENT OPINION IN PEDIATRICS (2011)
Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens
Fabrice Godfroid et al.
INFECTION AND IMMUNITY (2011)
Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
Julie M. Skinner et al.
VACCINE (2011)
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage
Roman Prymula et al.
VACCINE (2011)
Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta-Analysis
Daniel M. Weinberger et al.
CLINICAL INFECTIOUS DISEASES (2010)
Increasing Incidence of Empyema Complicating Childhood Community-Acquired Pneumonia in the United States
Carlos G. Grijalva et al.
CLINICAL INFECTIOUS DISEASES (2010)
Streptococcus pneumoniae: virulence factors and variation
A. M. Mitchell et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13 (R)]
Sean T. Duggan
DRUGS (2010)
Immunization with a Combination of Three Pneumococcal Proteins Confers Additive and Broad Protection against Streptococcus pneumoniae Infections in Mice
Kaifeng Wu et al.
INFECTION AND IMMUNITY (2010)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Occult Pneumococcal Bacteremia A Review
Mark D. Joffe et al.
PEDIATRIC EMERGENCY CARE (2010)
Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine
Su-Ting T. Li et al.
PEDIATRICS (2010)
Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use
Tamar Pilishvili et al.
PEDIATRICS (2010)
Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children
Sheldon L. Kaplan et al.
PEDIATRICS (2010)
Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
Jaime L. Rubin et al.
VACCINE (2010)
Declining invasive pneumococcal disease mortality in the United States, 1990-2005
Marifi Pulido et al.
VACCINE (2010)
A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination
Thierry Van Effelterre et al.
VACCINE (2010)
Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae
R. Dagan
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF VACCINES (2009)
Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung
Maria T. Arevalo et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine
Moon H. Nahm et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease
Chun Meng et al.
MICROBIAL PATHOGENESIS (2009)
Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Heather E. Hsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
Nancy Bermal et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome
Simon Rueckinger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Susan S. Huang et al.
PEDIATRICS (2009)
Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection
Julio Villena et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2008)
Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine
Rochelle Lacapa et al.
CLINICAL INFECTIOUS DISEASES (2008)
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members
Eugene V. Millar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Changing epidemiology of invasive pneumococcal disease: a complicated story
Steven Black
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine
Carmen Munoz-Almagro et al.
CLINICAL INFECTIOUS DISEASES (2008)
Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States
Chiaojung Jillian Tsai et al.
CLINICAL INFECTIOUS DISEASES (2008)
Population snapshot of emergent streptococcus pneumoniae serotype 19A in the United States, 2005
Matthew R. Moore et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents
Dea M. Cardozo et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Impact of conjugate pneumococcal vaccines on antibiotic resistance
Ron Dagan et al.
LANCET INFECTIOUS DISEASES (2008)
FIVE-FOLD INCREASE IN PEDIATRIC PARAPNEUMONIC EMPYEMA SINCE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE
Debra J. Hendrickson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses
Sigurveig Th. Sigurdardottir et al.
VACCINE (2008)
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
Jennifer C. Nelson et al.
VACCINE (2008)
The changing epidemiology of pneumococcal pulmonary disease in the era of the heptavalent vaccine
Catherine A. Lexau
Current Infectious Disease Reports (2008)
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
Carmen Giefing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the united states
Fangjun Zhou et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2007)
Vaccine escape recombinants emerge after pneumococcal vaccination in the united states
Angela B. Brueggemann et al.
PLOS PATHOGENS (2007)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP
Ju Cao et al.
VACCINE (2007)
Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005
Allison F. Messina et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine
Keri L. Carstairs et al.
ANNALS OF EMERGENCY MEDICINE (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
Development of lactococcal GEM-based pneumococcal vaccines
Sandrine A. L. Audouy et al.
VACCINE (2007)
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
William P. Hausdorff
VACCINE (2007)
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)
Daniel J. Isaacman et al.
VACCINE (2007)
Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era
William P. Hanage et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States
David J. Farrell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection
Sean B. Hanniffy et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae:: An explanation of trends in invasive pneumococcal disease
LL Hammitt et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine
KA Poehling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
MH Kyaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia
AP Steenhoff et al.
CLINICAL INFECTIOUS DISEASES (2006)
Changing epidemiology of outpatient bacteremia in 3-to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine
AM Herz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Streptococcus pneumonide serogroups 15 and 33 -: An increasing cause of pneumococcal infections in children in the united states after the introduction of the pneumococcal 7-valent conjugate vaccine
BE Gonzalez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Trends in invasive pneumococcal disease-associated hospitalizations
SS Shah et al.
CLINICAL INFECTIOUS DISEASES (2006)
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States
R Pai et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
CA Lexau et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004
SS Huang et al.
PEDIATRICS (2005)
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine
SL Kaplan et al.
PEDIATRICS (2004)
Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States:: Evidence for clonal spread and the impact of conjugate pneumococcal vaccine
MWR Pletz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection
KP Klugman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein-conjugated pneumococcal vaccine in Filipino infants -: art. no. 17
MZR Capeding et al.
BMC INFECTIOUS DISEASES (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pneumococcal septic arthritis: Review of 190 cases
JJ Ross et al.
CLINICAL INFECTIOUS DISEASES (2003)
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence
P Mangtani et al.
LANCET INFECTIOUS DISEASES (2003)
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae
TQ Tan et al.
PEDIATRICS (2002)
Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
T Puumalainen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers
R Dagan et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 -: Opportunities for prevention in the conjugate vaccine era
KA Robinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine healthy toddlers
T Wuorimaa et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia
JA Brandenburg et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2000)
Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae
TJ Mitchell
RESEARCH IN MICROBIOLOGY (2000)
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
GS Nabors et al.
VACCINE (2000)
Share Paper
